Sort
4,870 grants matching “glp 1”
Project 1: Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$332,593David E Fisher · Massachusetts General Hospital · P01 · FY2022 · CA
The Effect of TCF7L2 on Glucose Metabolism
$332,420Adrian Vella · Mayo Clinic Rochester · R01 · FY2007 · DK
Insulinotropin: A Modulator Of B-Cell Glucose Signaling
$332,113New York University School Of Medicine · R01 · FY2003 · DK
Brainstem Mechanisms of Stress Regulation
$331,939James P Herman · University Of Cincinnati · R01 · FY2006 · MH
Foldamers: Novel Ligands for Diverse Protein Surfaces
$331,719Alanna Schepartz · Yale University · R01 · FY2011 · GM
Viral/Molecular Core
$331,522Ronald G Collman · University Of Pennsylvania · P30 · FY2015 · AI
High-definition Endoscopic Ultrasound Navigation for Targeted Dual Neuromodulation Therapy
$331,451Jon James Waataja · Reshape Lifesciences, Inc. · R43 · FY2023 · DK
ALZHEIMERS RESEARCH PROJECT: Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)
$331,188Nigel H. Greig · National Institute On Aging · ZIA · FY2025 · AG
Viral/Molecular Core
$331,157Ronald G Collman · University Of Pennsylvania · P30 · FY2016 · AI
Mechanisms of insulin secretion mediated by alpha cells
$331,148Jonathan E Campbell · Duke University · R01 · FY2020 · DK
Prostatic Effects of Chronic Exposure to Bisphenol A in a Rat Model
$331,143Gail S Prins · University Of Illinois At Chicago · U01 · FY2013 · ES
Foldamers: Novel Ligands for Diverse Protein Surfaces
$330,803Alanna Schepartz · Yale University · R01 · FY2010 · GM
Gut microbiota mediates the interplay between immunity and glucose metabolism
$330,750Natalia Shulzhenko · Oregon State University · R01 · FY2017 · DK
Gut microbiota mediates the interplay between immunity and glucose metabolism
$330,750Natalia Shulzhenko · Oregon State University · R01 · FY2019 · DK
Project 1: Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$330,547David E Fisher · Massachusetts General Hospital · P01 · FY2023 · CA
Improving beta-cell function in Mexican American women with prediabetes
$330,161Willa A. Hsueh · Ohio State University · R01 · FY2018 · MD
Appetite Hormones in Binge Eating Disorder
$329,997Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2010 · DK
GCPII Inihibitors for the treatment of chemotherapy-induced neuropathy
$329,947Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2012 · CA
Large Animal (Dog) experimental support module
$329,869Gustavo David Aguirre · University Of Pennsylvania · R24 · FY2012 · EY
Catalytic antioxidant for toxic inhaled chemicals
$329,834Brian J Day · National Jewish Health · U54 · FY2011 · ES
Arylepoxamides: A new class of potent, safer analgesics
$329,534Ying-Xian Pan · Sloan-Kettering Inst Can Research · UG3 · FY2021 · DA
Long Acting Local Analgesics: HSV-CA8 Biotherapeutics
$329,297Roy Clifford Levitt · University Of Miami School Of Medicine · R21 · FY2018 · NS
BPA as a Developmental Carcinogen
$329,078Ana Soto · Tufts University Boston · U01 · FY2012 · ES
Insulinotropin: A Modulator Of B-Cell Glucose Signaling
$328,732New York University School Of Medicine · R01 · FY2002 · DK
Phentermine/Topiramate in children, adolescents, and young adults with hypothalamic obesity: a pilot and feasibility study
$328,635Christian Ludwig Roth · Seattle Children'S Hospital · R01 · FY2024 · DK